Page last updated: 2024-08-23

vindesine and Pleural Effusion, Malignant

vindesine has been researched along with Pleural Effusion, Malignant in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazawa, N; Yokoi, K1
Akiyama, Y; Fujii, Y; Kondo, H; Shirono, R1
Li, D; Wu, Z; Zhang, Z1

Trials

1 trial(s) available for vindesine and Pleural Effusion, Malignant

ArticleYear
[Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection (observation of 60 cases)].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2001, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Routes; Drug Tolerance; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Survival Rate; Vindesine

2001

Other Studies

2 other study(ies) available for vindesine and Pleural Effusion, Malignant

ArticleYear
Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1996, Volume: 10, Issue:2

    Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Pneumonectomy; Survival Rate; Vindesine

1996
[A case of lung adenocarcinoma associated with remarkably high levels of CA 19-9 and lymphangitis carcinomatosa].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Cisplatin; Humans; Lung Neoplasms; Lymphangitis; Male; Pleural Effusion, Malignant; Vindesine

1997